| Targeting ECM disrupts cancer progression FA Venning, L Wullkopf, JT Erler Frontiers in oncology 5, 224, 2015 | 285 | 2015 |
| Cancer cells’ ability to mechanically adjust to extracellular matrix stiffness correlates with their invasive potential L Wullkopf, AKV West, N Leijnse, TR Cox, CD Madsen, LB Oddershede, ... Molecular biology of the cell 29 (20), 2378-2385, 2018 | 226 | 2018 |
| Basement membrane stiffness determines metastases formation R Reuten, S Zendehroud, M Nicolau, L Fleischhauer, A Laitala, ... Nature materials 20 (6), 892-903, 2021 | 114 | 2021 |
| Endogenous transforming growth factor‐beta promotes quiescence of primary microglia in vitro B Spittau, L Wullkopf, X Zhou, J Rilka, D Pfeifer, K Krieglstein Glia 61 (2), 287-300, 2013 | 100 | 2013 |
| ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung AR Nobre, E Dalla, J Yang, X Huang, L Wullkopf, E Risson, P Razghandi, ... Nature Cancer 3 (10), 1165-1180, 2022 | 40 | 2022 |
| A negative regulatory mechanism involving 14-3-3ζ limits signaling downstream of ROCK to regulate tissue stiffness in epidermal homeostasis J Kular, KG Scheer, NT Pyne, AH Allam, AN Pollard, A Magenau, ... Developmental cell 35 (6), 759-774, 2015 | 40 | 2015 |
| Filopodia rotate and coil by actively generating twist in their actin shaft N Leijnse, YF Barooji, MR Arastoo, SL Sønder, B Verhagen, L Wullkopf, ... Nature communications 13 (1), 1636, 2022 | 33 | 2022 |
| Three-dimensional organotypic matrices from alternative collagen sources as pre-clinical models for cell biology JRW Conway, C Vennin, AS Cazet, D Herrmann, KJ Murphy, SC Warren, ... Scientific Reports 7 (1), 16887, 2017 | 31 | 2017 |
| Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer FA Venning, KW Zornhagen, L Wullkopf, J Sjölund, C Rodriguez-Cupello, ... Journal of Experimental & Clinical Cancer Research 40 (1), 175, 2021 | 30 | 2021 |
| Dynamics of cancerous tissue correlates with invasiveness AKV West, L Wullkopf, A Christensen, N Leijnse, JM Tarp, J Mathiesen, ... Scientific reports 7 (1), 43800, 2017 | 22 | 2017 |
| Division induced dynamics in non-Invasive and invasive breast cancer AKV West, L Wullkopf, A Christensen, N Leijnse, JM Tarp, J Mathiesen, ... Biophysical Journal 112 (3), 123a, 2017 | 22 | 2017 |
| Targeting ECM disrupts cancer progression. Front Oncol 5: 224 FA Venning, L Wullkopf, JT Erler | 9 | 2015 |
| Friction-limited cell motility in confluent monolayer tissue A Christensen, AKV West, L Wullkopf, J Terra Erler, LB Oddershede, ... Physical Biology 15 (6), 066004, 2018 | 7 | 2018 |
| Amidated peptides and their deamidated counterparts displayed by non-hla-a* 02 for use in immunotherapy against different types of cancers J Hukelmann, H Schuster, L Wullkopf, C Schraeder, J Fritsche, ... US Patent App. 18/433,919, 2024 | | 2024 |
| Amidated peptides and their deamidated counterparts displayed by non-hla-a* 02 for use in immunotherapy against different types of cancers J Hukelmann, H Schuster, L Wullkopf, C Schraeder, J Fritsche, ... US Patent App. 18/433,933, 2024 | | 2024 |
| Amidated peptides and their deamidated counterparts displayed by non-hla-a* 02 for use in immunotherapy against different types of cancers J Hukelmann, H Schuster, L Wullkopf, C Schraeder, J Fritsche, ... US Patent App. 18/433,940, 2024 | | 2024 |
| Amidated peptides and their deamidated counterparts displayed by non-hla-a* 02 for use in immunotherapy against different types of cancers J Hukelmann, H Schuster, L Wullkopf, C Schraeder, J Fritsche, ... US Patent App. 18/433,894, 2024 | | 2024 |
| Amidated peptides and their deamidated counterparts displayed by non-hla-a* 02 for use in immunotherapy against different types of cancers J Hukelmann, H Schuster, L Wullkopf, C Schraeder, J Fritsche, ... US Patent App. 18/433,852, 2024 | | 2024 |
| Amidated peptides and their deamidated counterparts displayed by non-hla-a* 02 for use in immunotherapy against different types of cancers J Hukelmann, H Schuster, L Wullkopf, C Schraeder, J Fritsche, ... US Patent App. 18/433,913, 2024 | | 2024 |
| Amidated peptides and their deamidated counterparts displayed by non-hla-a* 02 for use in immunotherapy against different types of cancers J Hukelmann, H Schuster, L Wullkopf, C Schraeder, J Fritsche, ... US Patent App. 18/421,972, 2024 | | 2024 |
Lene B. OddershedeProfessor of Physics, Niels Bohr Institute在 nbi.dk 的电子邮件经过验证
